Table 2.
Demographics for study participants
| Age | Sex | Handedness | Stroke | Affected side | Days Post | Pre FMA UE |
Pre ARAT |
Pre FIM |
Post FMA UE | Post ARAT | Post FIM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Robot therapy group | |||||||||||
| 62 | M | R | R VA | L | 28 | 15 | 0 | 64 | 23 | 12 | 70 |
| 31 | M | R | R PCA Hem | L | 86 | 25 | 6 | 98 | 34 | 14 | 104 |
| 66 | M | R | L MCA | R | 24 | 63 | 53 | 79 | 64 | 53 | 113 |
| 43 | M | L | L MCA | R | 53 | 17 | 0 | 76 | 19 | 5 | 90 |
| 53 | M | R | L PCA Hem | R | 20 | 33 | 8 | 77 | 48 | 29 | 110 |
| 56 | M | R | L MCA & ACA | R | 58 | 13 | 3 | 86 | 15 | 4 | 103 |
| 64 | F | R | R BA & PCA | L | 69 | 46 | 53 | 120 | 52 | 56 | 121 |
| 35 | M | R | R MCA | L | 8 | 37 | 12 | 79 | 57 | 44 | 115 |
| 79 | M | R | R MCA | L | 39 | 40 | 20 | 85 | 50 | 32 | 86 |
| Control group | |||||||||||
| 65 | M | R | L MCA | R | 9 | 65 | 55 | 111 | 64 | 57 | 121 |
| 68 | M | R | R MCA | L | 51 | 11 | 3 | 91 | 12 | 3 | N/A |
| 82 | M | R | R MCA | L | 28 | 12 | 3 | 86 | 11 | 0 | 103 |
| 50 | M | L | L BA Hem | R | 42 | 51 | 37 | 106 | 51 | 34 | 111 |
| 60 | F | L | R MCA | L | 62 | 9 | 3 | 69 | 9 | 3 | N/A |
| 26 | M | R | L MCA | R | 47 | 12 | 3 | N/A | 15 | 3 | N/A |
| 58 | M | R | R BA | L | 26 | 45 | 38 | 93 | 56 | 47 | 109 |
| 68 | M | R | R PCA & L PICA | L | 23 | 46 | 26 | N/A | 51 | 28 | N/A |
| 48 | M | R | R MCA | L | 36 | 52 | 29 | 111 | 50 | 40 | 116 |
| 52 | M | R | R MCA | L | 44 | 17 | 4 | 104 | 27 | 4 | 119 |
Demographic information for all participants included in this pilot study. All strokes were ischemic except when ‘Hem.’ is listed to indicate a hemorrhage. BA basilar artery, MCA middle cerebral artery, PCA posterior cerebral artery, PICA posterior inferior cerebellar artery, VA vertebral artery